Cardinal Health to Acquire AccessClosure 
|
By HospiMedica International staff writers Posted on 20 Apr 2014 |
|
Image: The Mynx Ace vascular closure device (Photo courtesy of AccessClosure).
Cardinal Health (Dublin, OH, USA) has signed an agreement to acquire AccessClosure (Santa Clara, CA, USA), a manufacturer and distributor of extravascular closure devices, for USD 320 million.
Cardinal Health hopes that the purchase will boost its interventional devices segment with the addition of the Mynx polyethylene glycol (PEG) vascular closure devices, biodegradable vascular sealant devices that help physicians to seal the femoral artery using a unique, secure, sealant which dissolves within 30 days, leaving nothing behind but a healed artery. The deal also aligns Cardinal Health with trending market forces and customers' need for value-driven care and comprehensive healthcare solutions in the interventional cardiology area.
“We are excited about this opportunity because it provides a scalable platform – with an outstanding product, strong customer base, cost-effective service model, and seasoned management team,” said Don Casey, CEO of Cardinal Health’s Medical Segment. “Our goal is to become the partner of choice for solutions that improve patient care while reducing the cost and complexity of procedures for hospital systems.”
“We are extremely pleased to join a healthcare solutions company like Cardinal Health which has existing scale and a structure to grow this business more rapidly and meet the needs of our current and future customers,” said Gregory Casciaro, president and CEO of AccessClosure. “With Cardinal Health’s resources and customer relationships, we can now more readily answer market demand for our innovative solutions that improve both the doctor and patient experience.”
Related Links:
Cardinal Health
AccessClosure
Cardinal Health hopes that the purchase will boost its interventional devices segment with the addition of the Mynx polyethylene glycol (PEG) vascular closure devices, biodegradable vascular sealant devices that help physicians to seal the femoral artery using a unique, secure, sealant which dissolves within 30 days, leaving nothing behind but a healed artery. The deal also aligns Cardinal Health with trending market forces and customers' need for value-driven care and comprehensive healthcare solutions in the interventional cardiology area.
“We are excited about this opportunity because it provides a scalable platform – with an outstanding product, strong customer base, cost-effective service model, and seasoned management team,” said Don Casey, CEO of Cardinal Health’s Medical Segment. “Our goal is to become the partner of choice for solutions that improve patient care while reducing the cost and complexity of procedures for hospital systems.”
“We are extremely pleased to join a healthcare solutions company like Cardinal Health which has existing scale and a structure to grow this business more rapidly and meet the needs of our current and future customers,” said Gregory Casciaro, president and CEO of AccessClosure. “With Cardinal Health’s resources and customer relationships, we can now more readily answer market demand for our innovative solutions that improve both the doctor and patient experience.”
Related Links:
Cardinal Health
AccessClosure
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Monitor/Defibrillator
Zenix
New
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Latest Business News
- Johnson & Johnson Launches AI-Driven Cardiac Mapping System
- Proximie Advances AI-Driven Intelligent Operating Rooms with NVIDIA Collaboration
- GE HealthCare, DeepHealth Expand AI Breast Imaging Collaboration
- Sinocare Presents AI-Driven Integrated Digital Health Solutions at CMEF
- GE HealthCare and Medtronic Expand Alliance with Intraoperative Imaging Integration
- New Partnership Advances Physical AI into Perioperative Workflows
- External Liver Assist System Receives FDA RMAT Designation
- New Partnership Expands Access to Predictive Tool for Patient Monitoring
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
Channels
Artificial Intelligence
view channel
AI Model Uses Eye Imaging to Identify Risk of Major Systemic Diseases
Early detection of systemic disease risk remains a persistent challenge in population health screening. Cardiometabolic conditions such as diabetes, heart disease, and stroke often progress without symptoms... Read more
AI Platform Interprets Real-Time Wearable Data for Parkinson’s Management
Parkinson’s disease presents fluctuating motor and non-motor symptoms that complicate day-to-day self-management and clinical decision-making. Care teams require timely, longitudinal insight into medication... Read more
Critical Care
view channel
Magnetic Control System Enables Precise Navigation of Miniature Medical Devices
Oncology procedures require precise navigation and targeted delivery inside the body, yet current tools provide limited control in complex anatomy. Invasive surgery and systemic chemotherapy can injure... Read more
Noninvasive Skull Sensor Detects Early Deterioration in Acute Brain Injury
Critically ill patients with traumatic brain injury or stroke can suffer secondary brain damage even when standard intracranial pressure and blood pressure targets appear adequate. Such injury arises from... Read more
Bacteria-Resistant Urinary Catheter Coating Reduces Infections and Antibiotic Use
Catheter-associated urinary tract infections (CAUTIs) are a major hospital-acquired infection, responsible for about 75% of urinary tract infections acquired in hospitals. They increase morbidity and drive... Read more
Surgical Techniques
view channel
New AI Tool Predicts Complications Before Lung Cancer Surgery
Lung cancer remains a leading cause of cancer mortality, and many surgical candidates present with complex comorbidities. Postoperative complications are common, making accurate and individualized risk... Read more
First Automated Insulin Delivery System Cleared for Type 1 Diabetes in Pregnancy
Managing glycemia during pregnancy complicated by type 1 diabetes requires tight targets and sustained time in a pregnancy-specific glucose range. Clinicians and patients often rely on automated insulin... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
AI System Detects and Quantifies Chronic Subdural Hematoma
Viz.ai (San Francisco, CA, USA) announced a strategic commercialization collaboration with Johnson & Johnson (New Brunswick, NJ, USA) to expand access in the United States to the Viz Subdural solution... Read more
Continuous Monitoring Platform Detects Infection Risk Across Care Transitions
Patients leaving skilled nursing facilities often lose continuous physiologic monitoring, increasing the risk of undetected infection and delayed intervention. Nursing home residents are seven times more... Read more
